Stockreport

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year [CNBC]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF Now, analysts say the French biotech could be bought by a larger peer for as much $23 billion. “Abivax ticks all the boxes for a strategic acquisition,” Stifel analys [Read more]